![]()
|
|
||||||||
(Received for publication, November 29,
1994; and in revised form, December 22, 1994) CD14 is a 55-kDa glycoprotein which binds lipopolysaccharide
(LPS) and enables LPS-dependent responses in a variety of cells. Recent
limited proteolysis studies have implicated a region in CD14 between
amino acids 57 and 64 as being involved in LPS interaction. To
specifically assess the importance of this region with respect to LPS
binding, we constructed a mutant sCD14
(sCD14
Volume 270,
Number 10,
Issue of March 10, 1995 pp. 5219-5224
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
) lacking amino acids 57-64.
sCD14
was isolated from the serum-free
conditioned medium of this cell line, and, in all assays, the purified
protein failed to recognize LPS or enable LPS-dependent responses in
cells. We also demonstrated that the region between amino acids 57 and
64 is required for binding of a neutralizing CD14 mAb, MEM-18. Native
polyacrylamide gel electrophoresis assays were used to demonstrate that
MEM-18 and LPS compete for the same binding site on CD14. These data
strongly suggest that the region spanning amino acids 57-64 binds
LPS and that formation of sCD14LPS complex is required in order
for sCD14-mediated responses to occur.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Meng, P. Parroche, D. T. Golenbock, and C. J. McKnight The Differential Impact of Disulfide Bonds and N-Linked Glycosylation on the Stability and Function of CD14 J. Biol. Chem., February 8, 2008; 283(6): 3376 - 3384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koraha, N. Tsuneyoshi, M. Kimoto, J.-F. Gauchat, H. Nakatake, and K. Fukudome Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2 Clin. Vaccine Immunol., November 1, 2005; 12(11): 1292 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, C. C. Cramer, J. Scafidi, and A. E. Davis III N-Linked Glycosylation at Asn3 and the Positively Charged Residues within the Amino-Terminal Domain of the C1 Inhibitor Are Required for Interaction of the C1 Inhibitor with Salmonella enterica Serovar Typhimurium Lipopolysaccharide and Lipid A Infect. Immun., August 1, 2005; 73(8): 4478 - 4487. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fan, B. Zingarelli, O. M. Peck, G. Teti, G. E. Tempel, P. V. Halushka, and J. A. Cook Lipopolysaccharide- and gram-positive bacteria-induced cellular inflammatory responses: role of heterotrimeric G{alpha}i proteins Am J Physiol Cell Physiol, August 1, 2005; 289(2): C293 - C301. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-I. Kim, C. J. Lee, M. S. Jin, C.-H. Lee, S.-G. Paik, H. Lee, and J.-O. Lee Crystal Structure of CD14 and Its Implications for Lipopolysaccharide Signaling J. Biol. Chem., March 25, 2005; 280(12): 11347 - 11351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Sacre, E. Andreakos, M. Feldmann, and B. M. Foxwell Endotoxin signaling in human macrophages: signaling via an alternate mechanism Innate Immunity, December 1, 2004; 10(6): 445 - 452. [Abstract] [PDF] |
||||
![]() |
D. Liu, X. Gu, J. Scafidi, and A. E. Davis III N-Linked Glycosylation Is Required for C1 Inhibitor-Mediated Protection from Endotoxin Shock in Mice Infect. Immun., April 1, 2004; 72(4): 1946 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
Hongkuan Fan and J. A. Cook Review: Molecular mechanisms of endotoxin tolerance Innate Immunity, April 1, 2004; 10(2): 71 - 84. [Abstract] [PDF] |
||||
![]() |
M. d. J. Arana, M. G. Vallespi, G. Chinea, G. V. Vallespi, I. Rodriguez-Alonso, H. E. Garay, W. A. Buurman, and O. Reyes Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction Innate Immunity, October 1, 2003; 9(5): 281 - 291. [Abstract] [PDF] |
||||
![]() |
E. S. Van Amersfoort, T. J. C. Van Berkel, and J. Kuiper Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock Clin. Microbiol. Rev., July 1, 2003; 16(3): 379 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Gioannini, D. Zhang, A. Teghanemt, and J. P. Weiss An Essential Role for Albumin in the Interaction of Endotoxin with Lipopolysaccharide-binding Protein and sCD14 and Resultant Cell Activation J. Biol. Chem., November 27, 2002; 277(49): 47818 - 47825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muroi, T. Ohnishi, and K.-i. Tanamoto Regions of the Mouse CD14 Molecule Required for Toll-like Receptor 2- and 4-mediated Activation of NF-kappa B J. Biol. Chem., October 25, 2002; 277(44): 42372 - 42379. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iovine, J. Eastvold, P. Elsbach, J. P. Weiss, and T. L. Gioannini The Carboxyl-terminal Domain of Closely Related Endotoxin-binding Proteins Determines the Target of Protein-Lipopolysaccharide Complexes J. Biol. Chem., March 1, 2002; 277(10): 7970 - 7978. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. HWANG Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through Toll-like receptor 4-derived signaling pathways FASEB J, December 1, 2001; 15(14): 2556 - 2564. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nagaoka, S. Hirota, F. Niyonsaba, M. Hirata, Y. Adachi, H. Tamura, and D. Heumann Cathelicidin Family of Antibacterial Peptides CAP18 and CAP11 Inhibit the Expression of TNF-{alpha} by Blocking the Binding of LPS to CD14+ Cells J. Immunol., September 15, 2001; 167(6): 3329 - 3338. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Filipp, K. Alizadeh-Khiavi, C. Richardson, A. Palma, N. Paredes, O. Takeuchi, S. Akira, and M. Julius Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation PNAS, January 16, 2001; 98(2): 603 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sugiyama and S. D. Wright Soluble CD14 Mediates Efflux of Phospholipids from Cells J. Immunol., January 15, 2001; 166(2): 826 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baveye, E. Elass, D. G. Fernig, C. Blanquart, J. Mazurier, and D. Legrand Human Lactoferrin Interacts with Soluble CD14 and Inhibits Expression of Endothelial Adhesion Molecules, E-Selectin and ICAM-1, Induced by the CD14-Lipopolysaccharide Complex Infect. Immun., December 1, 2000; 68(12): 6519 - 6525. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dziarski, S. Viriyakosol, T. N. Kirkland, and D. Gupta Soluble CD14 Enhances Membrane CD14-Mediated Responses to Peptidoglycan: Structural Requirements Differ from Those for Responses to Lipopolysaccharide Infect. Immun., September 1, 2000; 68(9): 5254 - 5260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sugawara, E. Nemoto, H. Tada, K. Miyake, T. Imamura, and H. Takada Proteolysis of Human Monocyte CD14 by Cysteine Proteinases (Gingipains) from Porphyromonas gingivalis Leading to Lipopolysaccharide Hyporesponsiveness J. Immunol., July 1, 2000; 165(1): 411 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Cunningham, R. A. Shapiro, C. Seachord, K. Ratcliffe, L. Cassiano, and R. P. Darveau CD14 Employs Hydrophilic Regions to ""Capture"" Lipopolysaccharides J. Immunol., March 15, 2000; 164(6): 3255 - 3263. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matsuguchi, K. Takagi, T. Musikacharoen, and Y. Yoshikai Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes Blood, February 15, 2000; 95(4): 1378 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Viriyakosol, J. C. Mathison, P. S. Tobias, and T. N. Kirkland Structure-Function Analysis of CD14 as a Soluble Receptor for Lipopolysaccharide J. Biol. Chem., February 4, 2000; 275(5): 3144 - 3149. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stelter, H. Loppnow, R. Menzel, U. Grunwald, M. Bernheiden, R. S. Jack, A. J. Ulmer, and C. Schutt Differential Impact of Substitution of Amino Acids 9-13 and 91-101 of Human CD14 on Soluble CD14-Dependent Activation of Cells by Lipopolysaccharide J. Immunol., December 1, 1999; 163(11): 6035 - 6044. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Adachi, C. Satokawa, M. Saeki, N. Ohno, H. Tamura, S. Tanaka, and T. Yadomae Inhibition by a CD14 monoclonal antibody of lipopolysaccharide binding to murine macrophages Innate Immunity, June 1, 1999; 5(3): 139 - 146. [Abstract] [PDF] |
||||
![]() |
S. D. Wright Toll, A New Piece in the Puzzle of Innate Immunity J. Exp. Med., February 15, 1999; 189(4): 605 - 609. [Full Text] [PDF] |
||||
![]() |
R. Dziarski and D. Gupta Function of CD14 as a peptidoglycan receptor: differences and similarities with LPS Innate Immunity, February 1, 1999; 5(1-2): 56 - 61. [Abstract] [PDF] |
||||
![]() |
G. Zybarth, N. Reiling, H. Schmidtmayerova, B. Sherry, and M. Bukrinsky Activation-Induced Resistance of Human Macrophages to HIV-1 Infection In Vitro J. Immunol., January 1, 1999; 162(1): 400 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yu, E. Soprana, G. Cosentino, M. Volta, H. S. Lichenstein, G. Viale, and D. Vercelli Soluble CD141-152 Confers Responsiveness to Both Lipoarabinomannan and Lipopolysaccharide in a Novel HL-60 Cell Bioassay J. Immunol., October 15, 1998; 161(8): 4244 - 4251. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wooten, T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, and J. J. Weis The Role of CD14 in Signaling Mediated by Outer Membrane Lipoproteins of Borrelia burgdorferi J. Immunol., June 1, 1998; 160(11): 5485 - 5492. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Landmann, S. Link, S. Sansano, Z. Rajacic, and W. Zimmerli Soluble CD14 Activates Monocytic Cells Independently of Lipopolysaccharide Infect. Immun., May 1, 1998; 66(5): 2264 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dziarski, R. I. Tapping, and P. S. Tobias Binding of Bacterial Peptidoglycan to CD14 J. Biol. Chem., April 10, 1998; 273(15): 8680 - 8690. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mattern, H.-D. Flad, L. Brade, E. T. Rietschel, and A. J. Ulmer Stimulation of Human T Lymphocytes by LPS Is MHC Unrestricted, But Strongly Dependent on B7 Interactions J. Immunol., April 1, 1998; 160(7): 3412 - 3418. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yu and S. D. Wright Catalytic Properties of Lipopolysaccharide (LPS) Binding Protein J. Biol. Chem., February 23, 1996; 271(8): 4100 - 4105. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S.-C. Juan, E. Hailman, M. J. Kelley, S. D. Wright, and H. S. Lichenstein Identification of a Domain in Soluble CD14 Essential for Lipopolysaccharide (LPS) Signaling but Not LPS Binding J. Biol. Chem., July 21, 1995; 270(29): 17237 - 17242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. McGinley, L. O. Narhi, M. J. Kelley, E. Davy, J. Robinson, M. F. Rohde, S. D. Wright, and H. S. Lichenstein CD14: Physical Properties and Identification of an Exposed Site That Is Protected by Lipopolysaccharide J. Biol. Chem., March 10, 1995; 270(10): 5213 - 5218. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sano, H. Chiba, D. Iwaki, H. Sohma, D. R. Voelker, and Y. Kuroki Surfactant Proteins A and D Bind CD14 by Different Mechanisms J. Biol. Chem., July 14, 2000; 275(29): 22442 - 22451. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mitsuzawa, I. Wada, H. Sano, D. Iwaki, S. Murakami, T. Himi, N. Matsushima, and Y. Kuroki Extracellular Toll-Like Receptor 2 Region Containing Ser40-Ile64 but Not Cys30-Ser39 Is Critical for the Recognition of Staphylococcus aureus Peptidoglycan J. Biol. Chem., October 26, 2001; 276(44): 41350 - 41356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. da Silva Correia and R. J. Ulevitch MD-2 and TLR4 N-Linked Glycosylations Are Important for a Functional Lipopolysaccharide Receptor J. Biol. Chem., January 11, 2002; 277(3): 1845 - 1854. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |